Literature DB >> 15242017

Phycocyanin enhances secretary IgA antibody response and suppresses allergic IgE antibody response in mice immunized with antigen-entrapped biodegradable microparticles.

Chinami Nemoto-Kawamura1, Tomohiro Hirahashi, Takayuki Nagai, Haruki Yamada, Toshimitsu Katoh, Osamu Hayashi.   

Abstract

In the present study, we have investigated the effects of phycocyanin, a biliprotein of Spirulina platensis, on mucosal and systemic immune responses and allergic inflammation in C3H/HeN and BALB/cA mice. To induce the antigen-specific antibodies in the peripheral lymphoid tissues such as Peyer's patches and mesenteric lymph nodes, biodegradable ovalbumin-entrapped poly (DL-lactide-co-glycolide) particles were used as an antigen. Two weeks after the onset of phycocyanin ingestion, mice were immunized with an aqueous ovalbumin (OVA) solution. Starting at one week after the primary immunization, the mice were subjected to oral immunization with the biodegradable OVA microparticles twice a week. IgA, IgE and IgG1 antibodies were determined by ELISA. The OVA microparticles of 4-microm diameter successfully induced antigen-specific antibodies. In the mice that received phycocyanin treatment for 6 wk, a marked increase in the antigen-specific, as well as the total, IgA antibody level was observed in the Peyer's patches, mesenteric lymph nodes and intestinal mucosa as well as in the spleen cells. Both antigen-specific IgG1 and IgE antibody levels in the serum were suppressed by ingestion of phycocyanin for 8 wk. However, inflammation of the small intestine, monitored as vascular permeability by the Evans blue-leaking method was reduced by phycocyanin at 6 wk, which preceded the suppression of antigen-specific IgG1 and IgE antibody production by 2 wk. These results suggest that phycocyanin enhances biological defense activity against infectious diseases through sustaining functions of the mucosal immune system and reduces allergic inflammation by the suppression of antigen-specific IgE antibody.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242017     DOI: 10.3177/jnsv.50.129

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  7 in total

1.  Isolation, characterization and antioxidative activity of C-phycocyanin from Limnothrix sp. strain 37-2-1.

Authors:  Miroslav Gantar; Dragan Simović; Sonja Djilas; Walter W Gonzalez; Jaroslava Miksovska
Journal:  J Biotechnol       Date:  2012-02-14       Impact factor: 3.307

Review 2.  Edible Cyanobacterial Genus Arthrospira: Actual State of the Art in Cultivation Methods, Genetics, and Application in Medicine.

Authors:  Magda A Furmaniak; Agnieszka E Misztak; Martyna D Franczuk; Annick Wilmotte; Małgorzata Waleron; Krzysztof F Waleron
Journal:  Front Microbiol       Date:  2017-12-18       Impact factor: 5.640

3.  The In Vitro Anti-Tumor Activity of Phycocyanin against Non-Small Cell Lung Cancer Cells.

Authors:  Shuai Hao; Yan Yan; Shuang Li; Lei Zhao; Chan Zhang; Liyun Liu; Chengtao Wang
Journal:  Mar Drugs       Date:  2018-05-23       Impact factor: 5.118

4.  Phycocyanin Ameliorates Colitis-Associated Colorectal Cancer by Regulating the Gut Microbiota and the IL-17 Signaling Pathway.

Authors:  Dongjin Pan; Bingyao Huang; Yuman Gan; Chenghai Gao; Yonghong Liu; Zhenzhou Tang
Journal:  Mar Drugs       Date:  2022-04-09       Impact factor: 6.085

Review 5.  Advances in delivery methods of Arthrospira platensis (spirulina) for enhanced therapeutic outcomes.

Authors:  Omar Ashraf ElFar; Nashiru Billa; Hooi Ren Lim; Kit Wayne Chew; Wai Yan Cheah; Heli Siti Halimatul Munawaroh; Deepanraj Balakrishnan; Pau Loke Show
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

Review 6.  Phycobiliproteins-A Family of Algae-Derived Biliproteins: Productions, Characterization and Pharmaceutical Potentials.

Authors:  Huaxin Chen; Hongtao Qi; Peng Xiong
Journal:  Mar Drugs       Date:  2022-07-09       Impact factor: 6.085

Review 7.  Medical Application of Spirulina platensis Derived C-Phycocyanin.

Authors:  Qian Liu; Yinghong Huang; Ronghua Zhang; Tiange Cai; Yu Cai
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-11       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.